JAAPA CME Post-Test July 2023
Emerging Research on Postacute COVID-19 Complications
An estimated 21.5% of patients in the United States who have had COVID-19 report development of a prolonged postviral syndrome that has been called postacute sequelae of COVID-19 (PASC). Symptoms can range from very mild to debilitating damage to organ systems caused directly by the virus and indirectly by the body’s inflammatory response. Research into defining PASC and discovering effective treatments is ongoing. This activity discusses the common presentations of PASC in patients who have had COVID-19; describes specific effects on the pulmonary, cardiovascular, and central nervous systems; and identifies potential treatments based on current literature.
- Recognize the common symptoms associated with PASC
- Understand the potential long-term effects of COVID-19 on the pulmonary, cardiovascular, and central nervous systems
- Identify recommended treatment options for PASC as defined by current literature
Managing Patients With Sex-, Race-, or Ethnicity-Based Cardiovascular Health Inequities
Cardiovascular health inequities are experienced among cisgender women, gender minorities, Black and Indigenous people, and people with lower socioeconomic status. Early identification and treatment of patients at risk for disparate and adverse cardiac health outcomes are essential.
- Identify differences in diagnosis and treatment of CVD among cisgender women compared with cisgender men
- Recognize cardiovascular risk factors among transgender and gender-diverse patients
- Recognize the occurrence and prevention of racial differences in outcomes of CVD
- Develop awareness of the relationships among depression, anxiety, and ACS
AAPA offers no returns or refunds for online CME activities purchased via the AAPA store. All sales are final.